We assessed patient outcomes 90 days after hospital admission for stroke following a multidisciplinary intervention targeting evidence-based management of fever, hyper glycaemia, and swallowing dysfunction in acute stroke units (ASUs).
INTRODUCTION
Although organised stroke unit care significantly reduces death and disability from cerebrovascular, 1 three physiological variables are not yet universally well-managed despite their importance for long-term patient recovery. [2] [3] [4] In the first days of an acute stroke, temperature above 37·5ºC occurs in 20-50% of patients; 2 up to 50% of patients become hyperglycaemic; 3 and 37-78% 4 experience dysphagia; all result in increased morbidity and mortality. [2] [3] [4] Hence, international guidelines recommend that fever and elevated blood glucose levels be monitored and managed proactively and that every stroke patient has their swallowing status evaluated before receiving food, fluid or oral medication. 5, 6 All these recommendations are the responsibility of the stroke multidisciplinary team. 7 Care is not always consistent with these recommendations however. 6, 8 We designed the Quality in Acute Stroke Care (QASC) study, a cluster randomised controlled trial (CRCT), 9, 10 to evaluate the effect on 90-day post-stroke patient outcomes of multidisciplinary team building workshops and a standardised interactive education program to implement evidence-based treatment protocols for the management of fever, hyperglycaemia and swallowing dysfunction. These three parameters were selected because they involve multidisciplinary teamwork, which has been demonstrated to improve healthcare processes and patient outcomes, 11 a priority for stroke care.
METHOD
Our single blind CRCT design randomised Acute Stroke Units (ASUs) to minimise contamination because our team building intervention was designed for implementation at the ASU level. 12 Pre-and post-intervention outcomes were assessed at the patient level. The trial protocol previously has been published. 9 Participants ASUs eligible to participate were those located in large, tertiary referral centres in New South Wales (NSW), Australia who provided care for stroke patients in a geographically defined location with immediate CT access and on-site high dependency units (Australian National Stroke Unit Program Category A or B) (n=20). Category A ASUs have access to on-site neurosurgery while Category B do not. 13 Patients were eligible if they: spoke English, were aged over 18 years, had a diagnosis of ischaemic stroke or intracerebral haemorrhage and presented within 48 hours of onset of symptoms to a participating ASU. Patients were excluded if they did not have a telephone or were admitted for palliative care.
Pre-intervention patient cohort
Prior to randomisation, a pre-intervention patient cohort was recruited (August 2005 to October 2007) to provide a baseline sample prior to implementation of the intervention.
Patients consented to medical record access and to participation in a telephone survey 90days following hospital admission.
Post-intervention patient cohort
Using identical procedures and instruments, a second post-intervention patient cohort was recruited (February 2008 to August 2010) to provide a follow-up sample after intervention implementation.
Outcome Measures
All outcome measures pertained to the level of the individual (patient) and all used tools previously validated for telephone administration. [14] [15] [16] 1.
death or dependency (dependency: modified Rankin Scale (mRS) ≥ 2) 17 2.
functional dependency [Barthel Index (BI)] 18 3. mean SF-36 mental component summary (MCS) score 19 4. mean physical component summary (PCS) score 19 We also undertook subgroup analyses by stroke severity.
Secondary outcomes: Processes of care
1. mean temperature for the first 72 hours following ASU admission 2. mean finger-prick blood glucose level for the first 72 hours following ASU admission
3.
proportion with swallowing screening undertaken within the first 24 hours of ASU admission 4. discharge diagnosis of aspiration pneumonia (ICD 10)
length of hospital stay

Data Collection
90-day patient outcome instrument
An independent organisation was contracted to conduct Computer Assisted Telephone Interviews (CATIs) with patients 90-days following hospital admission. The two interviewers underwent on-line training and competency assessment for mRS administration.
Processes of Care
Blinded retrospective medical record audits were undertaken using data documented prospectively. Four auditors collected: age; sex; stroke sub-type (Oxfordshire Community Stroke Project classification); 20 time from onset of symptoms to ASU presentation; stroke severity (Los Angeles Motor Scale (LAMS)), 21 administration of thrombolysis; all temperature and blood glucose levels within the first 72 hours of admission to an ASU; swallowing screening performed within the first 24 hours of ASU admission; and discharge diagnosis of aspiration pneumonia. Auditors attended a 2-day training program. Two auditors abstracted data from 95% of medical records, enabling clarification of uncertainties. For quality assurance purposes, for the first 700 audits, 10% were re-audited with agreement occurring 95% of the time.
Randomisation
ASUs were stratified (Category A or B) and then by absolute numbers of pre-intervention cohort patients recruited. 'High' recruiters had consented more than two patients per month;
'low' recruiters two or fewer per month. De-identified stratification details were provided to an independent statistician who used random number generating software to randomise within strata with allocation concealed until provided to the Project Officer who assigned ASUs to their groups. Clinical Research Assistants blind to trial design enrolled patients.
Patients were blind to ASU group allocation but not clinicians delivering our intervention.
Research assistants who undertook the CATIs and the medical record audits were blind to trial aims, design and group allocation; the trial statistician was blind to group allocation.
Intervention
Our Fever, Sugar, Swallowing (FeSS) intervention targeted all ASU clinicians, focusing on barrier identification, 22 reinforcement of multidisciplinary teamwork, 23 local adaptation 24 and use of site champions. 25 Using recommendations from Australia's national clinical guidelines for stroke, 6 panels of experts developed clinical treatment protocols for management of fever, hyperglycaemia and swallowing for the first 72 hours following ASU admission (Box 1). We aimed to trigger prompt nursing assessment and bedside treatment. Specifically, two teambuilding workshops were conducted to identify local barriers to multidisciplinary care 22 and enablers to implementation of the nurse-initiated treatment protocols. Two additional site-based interactive and didactic educational outreach meetings, 26, 27 then were conducted for clinicians to discuss the protocols. On-going activities comprised reminders, 28 The intervention ran from May 2007 to August 2010. Following implementation, we allowed a three month 'bedding down' period prior to recruitment of the post-intervention cohort.
Data Analysis
Intention-to-treat analyses were undertaken using SAS v9·2 software. The Barthel Index is usually reported as a dichotomized variable but the cut points vary; we report both BI > 60 and BI > 95, the two most conventionally reported cut points in order to allow for comparison with published data. 18 Continuous and categorical data were summarised using conventional descriptive statistics. All outcomes including the sub-group analyses were adjusted for preintervention levels and for clustering within ASUs, using a logistic regression model fitted within a generalised estimating equation framework for dichotomous outcomes and a random intercept linear regression model for continuous outcomes. The linear and logistic models included the predictor variables of period (before and after), intervention and the interaction between period and intervention. The P-value from the Wald test for the interaction term was used to determine if the pre-post change in the intervention group was statistically different to the change in the control group. The confidence intervals reported are those for the interaction term from the logistic or linear model but to obtain estimates of absolute difference, the models for dichotomous outcomes were refit using an identity link function.
P-values for the interaction term from these models were almost identical to the logistic models.. In order to control the type 1 error rate from the four primary outcome measures, our
Alpha level was set at 0·0125.
We calculated each patient's mean temperature and blood glucose levels for the first 72 hours of their admission to the ASU and, using these, then determined a mean intervention and control ASU temperature and glucose level. Three elements were required to meet the criteria for swallowing screening, namely, assessment of level of consciousness; cranial nerve assessment; and water swallow test.
Sample Size
There were 19 clusters with a mean cluster size of 39 consenting patients in the preintervention cohort (median 31; minimum 10, maximum 83). In the post-intervention cohort the mean cluster size was 59 consenting patients (median 58; minimum: 13, maximum 145).
We achieved our desired sample size consistent with our earlier statistical assumptions. 9 This trial was approved by the Human Research Ethics Committee of Australian Catholic University and the relevant ethics committees of all participating hospitals. The trial was governed by a Steering Committee comprising all investigators and an Expert Advisory Committee comprising independent researchers and stroke clinicians.
RESULTS
Nineteen (95%) ASUs agreed to participate. Figure 1 represents cluster and participants' flow over the course of the trial.
Pre-Intervention Data
Data for the pre-intervention patient cohort have been published. 10 Age, sex, 90-day death, 90-day death and dependency, 90-day functional dependency (BI) and health status (PCS score and MCS score) were similar for the intervention and control groups.
Post-Intervention Cohort
Of and time between onset of stroke symptoms and arrival at ASU were similar for patients in the intervention and control groups although fulltime employment appeared slightly lower in the control group. (Table 1 ). Only 7% (n=77) received thrombolysis and the majority of these were in the control group (n=60, 78%).
90-day Outcomes
After adjusting for baseline levels, patients from intervention ASUs were significantly less likely to be dead or dependent at 90-days (mRS > 2) than patients from control ASUs (n=236 42% vs n=259, 58%, P=0·002) ( Figure 2 ) (number needed to treat (NNT) approximately 6·4; adjusted absolute difference: 15·7% (95% CI: 5·8 to 25·4). There was no significant difference in 90-day mortality between patients from intervention and control ASUs (n=21, 3·8% vs n=24, 5·3%, P=0·36) nor for functional dependency where BI > 60 (intervention n=487, 92% vs control n=380 90%, P=0·44) or BI > 95 (intervention n=367 69% vs control n=254 60%, P=0·07) ( Table 2) .
Patients from intervention ASUs were significantly more likely to have better SF-36 physical health scores indicating improved physical functioning (mean PCS score 45·6 vs 42·5, P=0·002) (adjusted absolute difference 3·4 (95% CI: 1·2 to 5·5)) but there were no significant differences for mental health (mean MCS score 49·5 vs 49·4, P=0·69) ( Table 2) .
Our exploratory sub-group analyses by stroke severity demonstrated that patients with a mild stroke (LAMS = 0) from intervention ASUs were significantly less likely to be dead or dependent at 90-days (mRS > 2) (n=56) than those from control ASUs (n=71) (25% vs 39%, P=0·02) and reported better physical health (PCS score mean 48·3 vs 45·0; p=0·008) than those from control ASUs. Similarly, patients with a more severe stroke (LAMS ≥ 1) from intervention group ASUs were significantly less likely to be dead or dependent at 90 days (mRS > 2) (n=178) than those from control ASUs (n=181) (54% vs 70%, P=0·04) and had better physical health (PCS score mean 43·6 vs 40·8; p=0·04) than patients from control ASUs. Further, intervention ASU patients with more severe strokes (n=17) were also less likely to have died at 90-days than patients from control ASUs (n=23) (5·2% vs 8·8%, P≤0·001).
Processes of Care
Medical records were unavailable for 40 patients (3·6%) resulting in collection of processes of care data for 1086 patients (intervention: n=603; control: n=483) ( (Table 3 ). There were no differences between aspiration pneumonia rates between groups [n=13, 2·2% vs n=13, 2·7%, P=0·82). The mean (SD) length of hospital stay was 11·3 (10·3) days for patients from intervention ASUs and 13·7 (12·7) days for patients from control ASUs (P=0·14).
Discussion
Our results demonstrate that patients of ASUs allocated to receive our multidisciplinary intervention to support proactive evidence-based management of fever, hyperglycaemia and swallowing were significantly more likely to be alive and less dependent at 90-days postadmission. Specifically, we found a 15·7% adjusted absolute difference in rates of 90 day death and dependency. The clinical significance of these results is more remarkable when compared against other established clinical and organisational interventions, namely administration of aspirin within 48 hours, 30 stroke unit care 1 and thrombolysis within 4·5 hours. 31 All deliver absolute benefit for independent survival of no more than 10%; all have higher NNT (aspirin NNT:79 30 ; stroke unit NNT: 18 1 ; thrombolysis: NNT: 8 32 to 14 31 depending on onset to treatment time) than our intervention to realise a benefit, with tPA available only to a very specific ischaemic stroke population, unlike our intervention which has relevance for all stroke patients. Hence, the 15·7% improvement and NNT of 6·4 seen with our FeSS intervention will be of immediate importance for clinicians, patients and their carers.
Furthermore, our data show that patients from ASUs who received our intervention also had significantly improved processes of care. The mean temperature decreased significantly by 0·1 (from 36·6ºC to 36·5ºC) in intervention ASU patients and, while this small difference occurred within the afebrile temperature range, our analyses incorporated all patients including those who never had a fever, making this change all the more potentially important.
That there were fewer patients with a fever in the intervention group also is of interest, possibly due to improved observation and early intervention. The mean glucose level also significantly decreased in patients receiving care in intervention ASUs (7·02 to 6·81 mmol/L), demonstrating the positive effect of our intervention on glucose management.
Although the proportion of swallowing screenings attended was significantly higher in patients from intervention ASUs when compared with patients from control group ASUs, the absolute performance appears low. We used very conservative screening criteria, however, and intentionally did not capture screening occurring outside the ASU, nor swallowing assessments that could also have had a screening component occurring within 24 hrs of admission. Although not shown to be significant, the promise of reduced length of stay also could represent substantial savings for hospitals.
Despite being implemented with multidisciplinary support from physicians, speech pathologists and nurses, our clinical protocols were delivered by bed-side nurses. Protocolled care enabled nurses to be proactive in their management of fever, hyperglycaemia and swallowing. Role delineation within multidisciplinary teams has clear benefit for patients, On a methodological note, we achieved excellent engagement (19 out of the 20 NSW ASUs), also recruiting large cohorts of patients with a modest rate of loss-to-follow-up (10%, n=117).
Of note, our death and dependency results remained significant (P=0·004) when a sensitivity analysis was undertaken where we assumed all patients lost to follow-up were dead or disabled (mRS > 2). Our extension of the data endpoints to encompass both 90-day patient outcomes and processes of care is exceptional in stroke research and we encourage similar scope in future studies.
Similar to many acute stroke studies, 33 our study was limited in that patients with severe strokes were under-represented. This under-representation was probably due to our deliberate exclusion of patients with severe stroke who were for palliation only. Exclusion of these patients also may account for the non-significant differences between groups in functional dependency and mortality. However, our sub-group analyses showed significant improvements for death and dependency outcomes for both mild and severe strokes in our intervention group (14% in the mild stroke cohort and 16% in the more severe stroke cohort)
showing a clear benefit for both mild and more severe strokes.
Other opportunities to improve patient outcomes have emerged. Prompt recognition of stroke in emergency departments and better triage are crucial for those eligible for thrombolysis and if new treatments such as the FeSS intervention 34 or early rehabilitation 35 are to be started, then timely admission to an ASU is imperative. As our intervention focussed on care of patients admitted to ASUs, our findings are not necessarily generalisable to stroke patients cared for in general medical wards. They also are only generalisable to patients admitted to
ASUs within 48 hours of symptom onset and who receive the protocol-led care for the first 72 hours following admission to an ASU. Because access to a stroke unit for all stroke patients is not always achievable and delays often occur, we recommend future trials to examine the effect of similar multidisciplinary interventions in general wards and emergency departments.
Our trial provides compelling evidence that better management of fever, hyperglycaemia and swallowing in acute stroke patients during the initial 72 hours of admission to an ASU can result in decreased rates of death, dependency and improved processes of care. Furthermore, ours is one of the few to clearly show the effect of good nursing care on death and depency.
Additionally, it is one of the first implementation trials in acute stroke to harness the stroke unit network in Australia. To our knowledge, it also is one of the largest multidisciplinary rigorously evaluated interventions in acute stroke. The importance of our intervention lies in its ability to augment the benefits of stroke unit care. Further research as to its potential to benefit stroke patients unable to access immediate stroke unit care and also its value for populations other than stroke is warranted.
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Contributions
Research in Context
Systematic review
In the first days of an acute stroke, temperature above 37.5ºC occurs in 20-50% of patients;
up to 68% of patients become hyperglycaemic; and 37% to 78% experience dysphagia, resulting in increased morbidity and mortality and enlarged infarct size. We searched MEDLINE and CINAHL databases using the search term 'stroke' (all inclusive) combined with: 'fever'; 'pyrexia'; 'hyperthermia'; 'hyperglycaemia'; and 'glucose' and determined there were no systematic reviews of treatments to effectively manage either physiological parameter.
Similarly, we also combined the term 'stroke' with 'dysphagia'; 'swallow/ deglutition'; and 'swallowing disorders/ deglutition disorders'. Evidence from a systematic review demonstrated that stroke patients with dysphagia are at risk of pneumonia and that this risk is higher in patients who aspirate. Use of a formal dysphagia screen can decrease the risk of pneumonia.
In addition, no studies have examined the combined effect of systematic management of fever, hyperglycaemia or swallowing. International guidelines recommend monitoring and prompt treatment of these three variables. There is no 'magic bullet', however, with which to change bedside care and ensure multidisciplinary teams comply with evidence-based clinical practice guidelines. Systematic reviews of strategies with this goal in mind persistently argue that more implementation research is needed to identify effective strategies and to ensure resources are not wasted on activities of questionable value. In response, our research tested a multidisciplinary intervention designed to raise standards of care in acute stroke units using a cluster randomised controlled trial. Barrier identification, educational meetings, use of local opinion leaders and reminders have shown promise in earlier studies in diverse clinical settings and we incorporated these elements in our intervention and evaluated long-term patient outcomes of 90-day death and dependency. We also examined processes of care.
Interpretation
The QASC trial provides high-quality evidence that a guideline implementation strategy to support multidisciplinary team work focussed on evidence-based management of three key physiological parameters delivers significantly better post-discharge outcomes for stroke patients. Clinical leaders of stroke services can adopt this strategy with confidence that their outcomes will improve. 49·4 (10·6) 49·5 (10·9) 0·69 0·5 (-1·9 to 2·8) † P-values are for the interaction term between intervention group and time period (pre or post intervention) and adjusted for clustering within ASU ^ Intra-cluster correlation co-efficient (ICC) 
Length of hospital stay (days)
Mean (SD) 13·7 (12·7) 11·3 (10·3) 0.144 1·5 (-0·5 to 3·5) † P-values are for the interaction term between intervention group and time period (pre or post intervention) and are adjusted for clustering within ASUs ^ Intra-cluster correlation co-efficient (ICC) # excludes those screened in ED
